captopril has been researched along with sb 202190 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Arens, C; Bader, M; Caglayan, E; Euler, G; Heger, J; Hinrichs, S; Rosenkranz, S; Schlüter, KD; Schreckenberg, R; Wenzel, S | 1 |
2 other study(ies) available for captopril and sb 202190
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Controlling cardiomyocyte length: the role of renin and PPAR-{gamma}.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Shape; Cells, Cultured; Endothelin-1; Enzyme Activation; Flavonoids; Imidazoles; Mannosephosphates; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Pioglitazone; PPAR gamma; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Transgenic; Receptor, IGF Type 2; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Renin; Thiazolidinediones; Time Factors | 2011 |